Suzhou Wangshan Wangshui Biomedical Co., Ltd.(referred to as "Wangshan Wangshui") was established in 2013. It is a comprehensive and integrated biomedical company committed to the discovery, development and commercialization of innovative small molecule drugs. The company is committed to meeting clinical needs in the fields of viral infection, neuropsychiatric and reproductive health. The company's founder team is from